{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:47:02Z","timestamp":1777088822773,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"am","delay-in-days":270,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.eplepsyres.2021.106644","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T01:48:44Z","timestamp":1618969724000},"page":"106644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Anticonvulsive profile of two GABAB receptor antagonists on acute seizure mice models"],"prefix":"10.1016","volume":"174","author":[{"given":"Nicole","family":"Pag\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Maurois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Bac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Meza-Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Peralta-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8935-9831","authenticated-orcid":false,"given":"Germ\u00e1n","family":"Chamorro-Cevallos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4765-5568","authenticated-orcid":false,"given":"Jos\u00e9 Melesio","family":"Crist\u00f3bal-Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4089-7663","authenticated-orcid":false,"given":"Joseph","family":"Vamecq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2021.106644_bib0005","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/epi.12657","article-title":"Antiepileptic activity of preferential inhibitors of persistent sodium current","volume":"55","author":"Anderson","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0010","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1523\/JNEUROSCI.18-11-04363.1998","article-title":"Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsants drugs and original assessment of neuroprotection properties","volume":"18","author":"Bac","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.pa.33.040193.000545","article-title":"GABAB receptor pharmacology","volume":"33","author":"Bowery","year":"1993","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0920-1211(92)90095-B","article-title":"Effects of 3-hydroxy, 3-ethyl, 3-phenylpropionamide (HEPP) on rat models of generalized and focal epilepsy","volume":"11","author":"Brailowsky","year":"1992","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0006-2952(64)90102-9","article-title":"Anticonvulsive action of substances designed as inhibitors of gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase","volume":"13","author":"Carvajal","year":"1964","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0030","first-page":"349","article-title":"Synthesis and pharmacological evaluation of a new homologous series of (+\/-)-p-fluoro-phenyl alcohol amide anticonvulsants","volume":"48","author":"Carvajal-Sandoval","year":"1998","journal-title":"Arzneimittelforschung \/Drug Res."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0035","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1021\/jm00017a016","article-title":"Phosphinic acid analogues of GABA. Selective, orally active GABAB agonists","volume":"38","author":"Froestl","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3565(25)05169-9","article-title":"Comparison of maximal seizures evoked by pentylenetetrazol (Metrol) and electroshock in mice, and their modification by anticonvulsants","volume":"108","author":"Goodman","year":"1953","journal-title":"J. Pharmacol. Exper. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.1321503","article-title":"The role of GABAB receptor activation in absence seizures of lethargic (Lh\/Lh) mice","volume":"257","author":"Hosford","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0050","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0022-3565(25)10680-0","article-title":"Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models","volume":"274","author":"Hosford","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neulet.2012.02.014","article-title":"GABA(B) receptor-mediated ERK1\/2 phosphorylation via a direct interaction with Ca(V)1.3 channels","volume":"513","author":"Im","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"223","key":"10.1016\/j.eplepsyres.2021.106644_bib0060","article-title":"Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system","volume":"18","author":"Jeremic","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0306-4522(92)90120-Q","article-title":"GABAB receptors in various in vitro and in vivo models of epilepsy: a study with the GABAB receptor blocker CGP 35348","volume":"47","author":"Karlsson","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0070","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0114-17.2017","article-title":"GABA-B controls persistent Na+ current and coupled Na+-Activated K+ current","volume":"4","author":"Li","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0306-4522(92)90340-8","article-title":"Involvement of intrathalamic GABAB neurotransmission in the control of absence seizures in the rat","volume":"48","author":"Liu","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0080","first-page":"131","article-title":"GABAB receptor involvement in the control of genetic absence seizures in rats","volume":"9","author":"Marescaux","year":"1992","journal-title":"Epilepsy Res. Suppl."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0085","first-page":"183","article-title":"Protective effect of severe magnesium deficiency on Plasmodium chabaudi infection","volume":"2","author":"Maurois","year":"1989","journal-title":"Magnes. Res."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0090","first-page":"1289","article-title":"A new homologous series of anticonvulsants: phenyl alcohol amides. Synthesis and pharmacological evaluation","volume":"40","author":"Meza-Toledo","year":"1990","journal-title":"Arzneimittelforschung\/Drug Res."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0095","first-page":"797","article-title":"Synthesis of a new homologous series of p-chlorophenyl alcohol amides, their anticonvulsant activity and their testing as potential GABAB receptor antagonists","volume":"48","author":"Meza-Toledo","year":"1998","journal-title":"Arzneimittelforschung\/Drug Res."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0100","first-page":"830","article-title":"Synthesis and pharmacological evaluation of some DL-dichlorophenyl alcohol amides anticonvulsants","volume":"54","author":"Meza-Toledo","year":"2004","journal-title":"Arzneimittelforschung."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0028-3908(76)90099-X","article-title":"Pentylenetetrazol: an antagonist of GABA at primary afferents of the isolated frog spinal cord","volume":"15","author":"Nicoll","year":"1976","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/mrc.1307","article-title":"Complete assignment of the 1H, 13C, 15N, 19F NMR spectra of nine DL-phenyl-alcoholamides anticonvulsants","volume":"42","author":"Peralta-Cruz","year":"2004","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00044-007-9016-9","article-title":"Structure\u2013activity relationship of phenytoinergic antiepileptic drugs related to ameltolide","volume":"16","author":"Philip","year":"2007","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0120","doi-asserted-by":"crossref","first-page":"588a","DOI":"10.1016\/j.bpj.2019.11.3189","article-title":"Antiepileptic drug ethosuximide may regulate absence seizures through different ion channels","volume":"118","author":"Shalomov","year":"2020","journal-title":"Biophys. J."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0125","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13129","article-title":"GABAB receptor attenuation of GABAA currents in neurons of the mammalian central nervous system","volume":"5","author":"Shen","year":"2017","journal-title":"Physiol. Rep."},{"issue":"Pt 3","key":"10.1016\/j.eplepsyres.2021.106644_bib0130","first-page":"715","article-title":"Modulation of GABA(A) receptor channel gating by pentobarbital","volume":"537","author":"Steinbach","year":"2001","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2183\/pjab.94.026","article-title":"Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling","volume":"94","author":"Terunuma","year":"2018","journal-title":"Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0026-895X(25)13512-8","article-title":"Binding of [3H]alpha-dihydropicrotoxinin, a gamma-aminobutyric acid synaptic antagonist, to rat brain membranes","volume":"14","author":"Ticku","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0145","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s10517-012-1806-5","article-title":"Functional aspects of neuroprotective effects of new salts and compositions of baclofen in the convulsive syndrome caused by electroshock","volume":"153","author":"Tyurenkov","year":"2012","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1523\/JNEUROSCI.17-02-00625.1997","article-title":"Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAA receptor","volume":"15","author":"Ueno","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2021.106644_bib0155","series-title":"Antiepileptic Drugs","first-page":"99","article-title":"General principles: experimental selection, quantification and evaluation of anticonvulsant drugs","author":"White","year":"1995"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:44:50Z","timestamp":1760276690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121121000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":31,"alternative-id":["S0920121121000978"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106644","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticonvulsive profile of two GABAB receptor antagonists on acute seizure mice models","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106644"}}